May 7: The Week in Cancer News
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Progress Against Cancer
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells (giving rise to myeloma). In 2020 alone, there were an estimated 1.3 million new blood cancer cases worldwide, which accounted for more than 5 percent of all cancer diagnoses that...
The FDA has granted accelerated approval to an immunotherapeutic to be used in combination with a targeted therapeutic and chemotherapy to treat certain patients with gastric or gastroesophageal junction adenocarcinomas. The U.S. Food and...
Many patients facing a cancer diagnosis ask their doctors a simple question: “What should I eat?” That elemental question has perplexed scientists for centuries. In a stirring discussion during the Opening Plenary session of...
President Biden resurfaces a proposal for a new health care agency, and more news of the week from Cancer Today.
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features and clinical outcomes vary widely between different cancer types, but they can even differ between individuals who have...
Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment and more cancer research news of the week from Cancer Today magazine.
The FDA has approved the targeted therapeutic loncastuximab tesirine-lpyl to treat certain adult patients with large B-cell lymphoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to loncastuximab tesirine-lpyl (Zynlonta) to...
The FDA has granted accelerated approval to an immunotherapy to treat certain adult patients with endometrial cancer that tests positive for a specific biomarker. The U.S. Food and Drug Administration (FDA) has granted accelerated...
Stool-based tests were favored over colonoscopy for colorectal cancer screening, according to research published in the AACR journal Cancer Prevention Research.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More